Processing of the human heparanase precursor and evidence that the active enzyme is a heterodimer

被引:167
作者
Fairbanks, MB
Mildner, AM
Leone, JW
Cavey, GS
Mathews, WR
Drong, RF
Slightom, JL
Bienkowski, MJ
Smith, CW
Bannow, CA
Heinrikson, RL [1 ]
机构
[1] Pharmacia & Upjohn Inc, Prot Sci, Kalamazoo, MI 49001 USA
[2] Pharmacia & Upjohn Inc, Genom Res, Kalamazoo, MI 49001 USA
[3] Pharmacia & Upjohn Inc, Struct Analyt & Med Chem, Kalamazoo, MI 49001 USA
[4] Pharmacia & Upjohn Inc, Res Operat, Kalamazoo, MI 49001 USA
关键词
D O I
10.1074/jbc.274.42.29587
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human platelet heparanase has been purified to homogeneity and shown to consist of two, non-covalently associated polypeptide chains of molecular masses 50 and 8 kDa. Protein sequencing provided the basis far determination of the full-length cDNA for this novel protein. Based upon this information and results from protein analysis and mass spectrometry, we propose a scheme to define the structural organization of heparanase in relation to its precursor forms, proheparanase and pre-proheparanase. The 8- and 50-kDa chains which make up the active enzyme reside, respectively, at the NH2- and COOH-terminal regions of the inactive: precursor, proheparanase. The heparanase heterodimer is produced by excision and loss of an internal linking segment. This paper is the first to suggest that human heparanase is a two-chain enzyme.
引用
收藏
页码:29587 / 29590
页数:4
相关论文
共 24 条
  • [1] VASCULAR BOUND RECOMBINANT EXTRACELLULAR SUPEROXIDE-DISMUTASE TYPE-C PROTECTS AGAINST THE DETRIMENTAL EFFECTS OF SUPEROXIDE RADICALS ON ENDOTHELIUM-DEPENDENT ARTERIAL RELAXATION
    ABRAHAMSSON, T
    BRANDT, U
    MARKLUND, SL
    SJOQVIST, PO
    [J]. CIRCULATION RESEARCH, 1992, 70 (02) : 264 - 271
  • [2] Caspases: the executioners of apoptosis
    Cohen, GM
    [J]. BIOCHEMICAL JOURNAL, 1997, 326 : 1 - 16
  • [3] Heparanase: Breaking down barriers in tumors
    Eccles, SA
    [J]. NATURE MEDICINE, 1999, 5 (07) : 735 - 736
  • [4] Cancer research - Potential target found for antimetastasis drugs
    Finkel, E
    [J]. SCIENCE, 1999, 285 (5424) : 33 - 34
  • [5] FREEMAN C, 1998, BIOCHEM J, V330, P1371
  • [6] Partial sequence of human platelet heparitinase and evidence of its ability to polymerize
    Gonzalez-Stawinski, GV
    Parker, W
    Holzknecht, ZE
    Huber, NS
    Platt, JL
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1999, 1429 (02): : 431 - 438
  • [7] CXC CHEMOKINES CONNECTIVE-TISSUE ACTIVATING PEPTIDE-III AND NEUTROPHIL-ACTIVATING PEPTIDE-2 ARE HEPARIN HEPARAN SULFATE-DEGRADING ENZYMES
    HOOGEWERF, AJ
    LEONE, JW
    REARDON, IM
    HOWE, WJ
    ASA, D
    HEINRIKSON, RL
    LEDBETTER, SR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (07) : 3268 - 3277
  • [8] Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
    Hulett, MD
    Freeman, C
    Hamdorf, BJ
    Baker, RT
    Harris, MJ
    Parish, CR
    [J]. NATURE MEDICINE, 1999, 5 (07) : 803 - 809
  • [9] Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2
    Kato, M
    Wang, HM
    Kainulainen, V
    Fitzgerald, ML
    Ledbetter, S
    Ornitz, DM
    Bernfield, M
    [J]. NATURE MEDICINE, 1998, 4 (06) : 691 - 697
  • [10] Cloning and functional expression of a human heparanase gene
    Kussie, PH
    Hulmes, JD
    Ludwig, DL
    Patel, S
    Navarro, EC
    Seddon, AP
    Giorgio, NA
    Bohlen, P
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (01) : 183 - 187